Clinical Trial Details
EORTC-04914
Back to Clinical Trials Database
Etude de phase II d'un nouveau derive du platine, le lobaplatine (SAR 540), dans les sarcomes avanc‚s des tissus mous de l'adulte
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 03-Mar-1992 Date Step1 close: 03-Nov-1993 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 25 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
